Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues    
Total revenues $ 41,316 $ 43,706
Cost of sales    
Total cost of sales 42,680 45,034
Gross profit (loss) (1,364) (1,328)
Operating expenses    
Research and development 23,144 24,605
Sales and marketing 9,607 19,689
General and administrative 18,202 23,857
Total operating expenses 50,953 68,151
Loss from operations (52,317) (69,479)
Interest expense (811) 32
Interest and other (expense) income, net (71) (1,753)
Loss before income taxes (53,199) (71,200)
Income tax benefit 557 1,256
Net loss $ (52,642) $ (69,944)
Net loss per share-Basic $ (0.16) $ (0.22)
Net loss per share-Diluted $ (0.16) $ (0.22)
Weighted average shares outstanding, basic 319,095,656 312,016,627
Weighted average shares outstanding, diluted 319,095,656 312,016,627
Products    
Revenues    
Total revenues $ 36,697 $ 39,476
Cost of sales    
Total cost of sales 38,891 41,902
Services    
Revenues    
Total revenues 4,619 4,230
Cost of sales    
Total cost of sales $ 3,789 $ 3,132